Advances in osteobiologics in spine surgery

Area of Science:

• Orthopedics
• Biomaterials Science
• Regenerative Medicine

Background:

• Spinal fusion relies on mature fixation devices, with biologics gaining prominence.
• Osteobiologics, including recombinant proteins and grafts, are increasingly used to enhance spinal fusion.
• The efficacy and safety data for these costly osteobiologic products vary significantly.

Purpose of the Study:

• To establish principles for evaluating current and future osteobiologic products in spine surgery.
• To provide a framework for surgeons to critically assess new biological agents.
• To discuss key examples of osteobiologics used in spinal fusion.

Main Methods:

• Review of current literature on osteobiologic products for spinal fusion.
• Analysis of principles for evaluating biological agents based on scientific evidence.
• Categorization and discussion of prominent osteobiologic examples.

Main Results:

• Identification of key criteria for assessing osteobiologic efficacy and safety.
• Highlighting the variability in evidence supporting different osteobiologic products.
• Discussion of diverse osteobiologic types, from proteins to grafts.

Conclusions:

• Surgeons require sophisticated evaluation methods for new osteobiologics.
• A structured approach is necessary to navigate the evolving landscape of spinal fusion biologics.
• Informed clinical decisions depend on rigorous assessment of osteobiologic evidence.